[Treatment of male breast cancer: an analysis of 41 cases]
- PMID: 8112159
[Treatment of male breast cancer: an analysis of 41 cases]
Abstract
41 male patients with breast cancer confirmed pathologically were treated. Of these, 35 were treated by radical mastectomy and 6 by modified radical mastectomy. The patients with axillary lymphatic metastasis were treated by postoperative radiotherapy, chemotherapy. The overall 5-, 10- and 15-year survival rates were 67.6%, 53.3% and 55.0%, respectively. The 15 year survival rates of TNM stage I-II and III patients were 55% and 50% respectively. We conclude that radical or modified radical mastectomy is the rational therapy for male breast cancer. The patients in stage III will benefit from postoperative adjuvant therapy in terms of improving prognosis.
Similar articles
-
[Clinical analysis of resectable breast cancer: a report of 6 263 cases].Ai Zheng. 2005 Mar;24(3):327-31. Ai Zheng. 2005. PMID: 15757535 Chinese.
-
[Carcinoma of the male breast. Review of the literature and case series contribution].Minerva Chir. 1990;45(13-14):947-52. Minerva Chir. 1990. PMID: 2177170 Italian.
-
The National Cancer Data Base report on the results of a large nonrandomized comparison of breast preservation and modified radical mastectomy.Cancer. 1997 Jul 1;80(1):162-7. Cancer. 1997. PMID: 9210722
-
Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy.Cancer. 1999 Apr 15;85(8):1773-81. Cancer. 1999. PMID: 10223572 Review.
-
The impact of resection margins in the treatment of primary sarcomas of the breast. A clinicopathological study of 8 cases with review of literature.Eur J Surg Oncol. 1993 Feb;19(1):61-9. Eur J Surg Oncol. 1993. PMID: 8436242 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical